NCT06046833View on ClinicalTrials.gov

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Gastroparesis With Diabetes Mellitus
Interventions
DEVICE

FreeStyle Libre 3 continuous glucose monitoring sensor

The Freestyle Libre 3 sensor is a small real-time continuous glucose monitor device that measures glucose levels every minute

OTHER

Nutritional drink

Balanced nutritional drink (Boost plus 8 ounces/237 mL)

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

Samita Garg

OTHER